Lymphocyte-rich Hodgkin lymphoma is a subtype of Hodgkin lymphoma characterized by a predominance of lymphocytes. It is associated with a favorable prognosis and can be effectively treated. The ICD-10 Code C81.4A is crucial for accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C81.4A represents Lymphocyte-rich Hodgkin lymphoma, in remission, indicating that the disease is currently not active. This code is used when documenting patients who have undergone treatment and are showing no signs of disease progression. Accurate coding is essential for proper billing and to reflect the patient's clinical status.
Lymphocyte-rich Hodgkin lymphoma is a rare form of Hodgkin lymphoma that features a high number of lymphocytes and is typically associated with a better prognosis. The condition requires medical attention due to its potential to progress if left untreated. Regular monitoring and appropriate treatment are essential for maintaining remission.
ICD-10 Code C81.4A is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's health status.
In SOAP notes, ICD-10 Code C81.4A connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of Lymphocyte-rich Hodgkin lymphoma, in remission. This ensures continuity of care and supports accurate billing and compliance with EHR documentation standards.
Management of Lymphocyte-rich Hodgkin lymphoma, in remission, focuses on monitoring and supportive care to maintain the patient's health status.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C81.4A is essential for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, low complexity. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C81.4A for Lymphocyte-rich Hodgkin lymphoma, in remission
What does it mean to be in remission from Lymphocyte-rich Hodgkin lymphoma?
Being in remission means that the signs and symptoms of Lymphocyte-rich Hodgkin lymphoma have decreased or disappeared following treatment. Regular monitoring is essential to ensure that the disease does not return.
How is Lymphocyte-rich Hodgkin lymphoma treated?
Treatment typically involves chemotherapy and may include radiation therapy. The specific regimen depends on the stage of the disease and the patient's overall health.
Is Lymphocyte-rich Hodgkin lymphoma contagious?
No, Lymphocyte-rich Hodgkin lymphoma is not contagious. It is a type of cancer that arises from the lymphatic system and cannot be transmitted from person to person.
What follow-up care is needed after remission?
Patients in remission should have regular follow-up appointments to monitor for any signs of recurrence. This may include physical exams, imaging studies, and blood tests.
Clinical Notes
SOAP notes
DAP notes
AI medical notes